Search Within

Eneda Toska

Formats
  1. Journal Article (15)
  2. Meeting Abstract (11)
  3. Review (2)
  4. Book Section (1)
  5. Research Letter (1)
Groups
  1. Sloan Kettering Institute Postdocs (30)
  2. GSK Faculty (22)
  3. Department of Medicine (20)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (18)
  5. Solid Tumor Oncology Division (18)
  6. Breast Medicine Service (17)

More Groups

People
  1. Maurizio Scaltriti (24)
  2. Jose Baselga (16)
  3. Pedram Razavi (13)
  4. Emiliano Cocco (11)
  5. Erik Ladewig (8)
  6. Guotai Xu (8)

More People

Years
  1. 2021 (3)
  2. 2020 (8)
  3. 2019 (9)
  4. 2018 (1)
  5. 2017 (3)
  6. 2016 (4)

More Years

Publications
  1. Cancer Research (9)
  2. Cancer Cell (2)
  3. Cancer Discovery (2)
  4. European Journal of Cancer (2)
  5. Science (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (13)
  2. American Association for the Advancement of Science (4)
  3. Cell Press (3)
  4. Elsevier Inc. (3)
  5. Nature Publishing Group (3)
  6. Amer Soc Clinical Investigation Inc (1)

More Publishers

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma
    Journal Article

    Mondello, P.; Tadros, S.; Teater, M.; Fontan, L.; Chang, A. Y.; Jain, N.; Yang, H.; Singh, S.; Ying, H. Y.; Chu, C. S.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Overview of the relevance of PI3K pathway in HR-positive breast cancer
    Review

    Vasan, N.; Toska, E.; Scaltriti, M.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Chromatin regulation at the intersection of estrogen receptor and PI3K pathways in breast cancer
    Review

    Castel, P.; Toska, E.
    Molecular and Cellular Oncology (2019)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Ka inhibitors
    Journal Article

    Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Lin, T. Y.; Toska, E.; more...
    Science (2019)

    Fulltext@MSK | Save
  • ARID1A is a critical regulator of luminal identity and therapeutic response in estrogen receptor-positive breast cancer
    Meeting Abstract

    Toska, E.; Xu, G.; Chhangawala, S.; Cocco, E.; Razavi, P.; Otto, J.; Cai, Y.; Chan, C.; D'Avino, D. R.; Collings, C.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation
    Meeting Abstract

    Cocco, E.; Kulick, A.; Misale, S.; Yaeger, R.; Razavi, P.; Won, H. H.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; Cownie, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis enhance oncogene activation and sensitivity to PI3K alpha inhibitors in breast cancer
    Meeting Abstract

    Vasan, N.; Razavi, P.; Johnson, J.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Toska, E.; Xu, G.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • PI3K pathway mediated splicing defects in ER+ breast cancers
    Meeting Abstract

    Ladewig, E.; Fairchild, L.; Scaltriti, M.; Leslie, C.; Toska, E.; Baselga, J.
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAPK pathway activation
    Research Letter

    Cocco, E.; Schram, A. M.; Kulick, A.; Misale, S.; Won, H. H.; Yaeger, R.; Razavi, P.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • PI3K inhibition activates SGK1 via a feedback loop to promote chromatin-based regulation of ER-dependent gene expression
    Journal Article

    Toska, E.; Castel, P.; Chhangawala, S.; Arruabarrena-Aristorena, A.; Chan, C.; Hristidis, V. C.; Cocco, E.; Sallaku, M.; Xu, G.; Park, J.; more...
    Cell Reports (2019)

    Fulltext@MSK | Save